Home/Filings/4/0001013606-19-000132
4//SEC Filing

Thompson Matthew 4

Accession 0001013606-19-000132

CIK 0001013606other

Filed

Aug 5, 8:00 PM ET

Accepted

Aug 6, 5:15 PM ET

Size

6.8 KB

Accession

0001013606-19-000132

Insider Transaction Report

Form 4
Period: 2019-08-05
Thompson Matthew
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-08-05+30,43384,244 total
  • Award

    Option to Purchase

    2019-08-05$6.67/sh+60,867$405,98360,867 total
    Exercise: $6.67From: 2019-09-05Exp: 2029-08-05Common Stock (60,867 underlying)
Footnotes (2)
  • [F1]Performance restricted stock unit award based on predetermined goals.
  • [F2]Options vest ratably over thirty-six months.

Issuer

ENDOLOGIX INC /DE/

CIK 0001013606

Entity typeother

Related Parties

1
  • filerCIK 0001740988

Filing Metadata

Form type
4
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 5:15 PM ET
Size
6.8 KB